Erratum: Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929)

Coghill A.EPfeiffer R.MProietti CHsu W.-LChien Y.-CLekieffre LKrause LTeng APablo JYu K.JPEI-JEN LOUCHENG-PING WANGLiu ZChen C.-JMiddeldorp JMulvenna JBethony JHildesheim ADoolan D.L.2020-10-272020-10-2720201078-0432https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087473944&doi=10.1158%2f1078-0432.CCR-20-1828&partnerID=40&md5=04b226b7452badddea28bc84754add77https://scholars.lib.ntu.edu.tw/handle/123456789/518176[SDGs]SDG3Erratum: Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan (Clinical Cancer Research (2018) 24 (1305–1314) DOI: 10.1158/1078-0432.CCR-17-1929)erratum10.1158/1078-0432.CCR-20-1828326116292-s2.0-85087473944